Financials Taiflex Scientific Co., Ltd.

Equities

8039

TW0008039009

Semiconductors

End-of-day quote Taiwan S.E. 23:00:00 12/05/2024 BST 5-day change 1st Jan Change
52.3 TWD +2.15% Intraday chart for Taiflex Scientific Co., Ltd. +1.55% +6.63%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 7,110 10,038 11,418 9,933 8,616 10,257
Enterprise Value (EV) 1 6,933 9,312 10,503 10,083 9,079 11,024
P/E ratio 10.7 x 16 x 14.9 x 15.9 x 14.4 x 28.4 x
Yield 7.35% 5.21% 4.58% 5.26% 6.07% 2.04%
Capitalization / Revenue 0.74 x 1.32 x 1.3 x 1.06 x 0.99 x 1.26 x
EV / Revenue 0.72 x 1.23 x 1.2 x 1.07 x 1.04 x 1.35 x
EV / EBITDA 5.49 x 8.93 x 7.86 x 7.74 x 8.77 x 12.3 x
EV / FCF -39.7 x 17.3 x 14.1 x -24.9 x -70.3 x 68.1 x
FCF Yield -2.52% 5.78% 7.1% -4.02% -1.42% 1.47%
Price to Book 0.98 x 1.39 x 1.53 x 1.28 x 1.09 x 1.28 x
Nbr of stocks (in thousands) 209,120 209,120 209,120 209,120 209,120 209,120
Reference price 2 34.00 48.00 54.60 47.50 41.20 49.05
Announcement Date 27/02/19 26/02/20 24/02/21 24/02/22 22/02/23 20/02/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 9,643 7,584 8,766 9,405 8,722 8,151
EBITDA 1 1,262 1,043 1,336 1,302 1,035 896
EBIT 1 969 738.1 1,043 948.8 648.1 487.6
Operating Margin 10.05% 9.73% 11.9% 10.09% 7.43% 5.98%
Earnings before Tax (EBT) 1 868.5 792.5 965.8 940.8 877.3 482.3
Net income 1 672.3 630.7 772.9 734.7 700.5 423
Net margin 6.97% 8.32% 8.82% 7.81% 8.03% 5.19%
EPS 2 3.180 3.000 3.670 2.979 2.867 1.727
Free Cash Flow 1 -174.7 538.5 746 -405.2 -129.1 161.8
FCF margin -1.81% 7.1% 8.51% -4.31% -1.48% 1.99%
FCF Conversion (EBITDA) - 51.65% 55.83% - - 18.06%
FCF Conversion (Net income) - 85.38% 96.52% - - 38.26%
Dividend per Share 2 2.500 2.500 2.500 2.500 2.500 1.000
Announcement Date 27/02/19 26/02/20 24/02/21 24/02/22 22/02/23 20/02/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 2,144 2,184 2,305 2,372 1,861
EBITDA - - - - -
EBIT 1 138.4 140.2 227 199.7 81.14
Operating Margin 6.45% 6.42% 9.85% 8.42% 4.36%
Earnings before Tax (EBT) 1 143.5 264.1 289.2 322 2.038
Net income 1 118.6 208.5 225.1 257 9.956
Net margin 5.53% 9.54% 9.77% 10.83% 0.54%
EPS 2 0.0500 1.000 0.9300 1.230 0.0500
Dividend per Share - - - - -
Announcement Date 24/02/22 27/04/22 27/07/22 25/10/22 22/02/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 149 463 766
Net Cash position 1 177 726 915 - - -
Leverage (Debt/EBITDA) - - - 0.1147 x 0.4472 x 0.8552 x
Free Cash Flow 1 -175 539 746 -405 -129 162
ROE (net income / shareholders' equity) 9.29% 8.39% 10.5% 9.62% 8.67% 4.48%
ROA (Net income/ Total Assets) 5.12% 3.96% 5.69% 4.63% 3.01% 2.36%
Assets 1 13,142 15,938 13,580 15,862 23,280 17,960
Book Value Per Share 2 34.70 34.70 35.70 37.10 37.80 38.20
Cash Flow per Share 2 8.910 12.40 8.580 15.60 10.80 9.400
Capex 1 464 788 551 529 977 1,015
Capex / Sales 4.82% 10.39% 6.29% 5.63% 11.2% 12.46%
Announcement Date 27/02/19 26/02/20 24/02/21 24/02/22 22/02/23 20/02/24
1TWD in Million2TWD
Estimates
  1. Stock Market
  2. Equities
  3. 8039 Stock
  4. Financials Taiflex Scientific Co., Ltd.